Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$0.571
-0.123 (-17.77%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.560 $0.80 Thursday, 9th May 2024 DBVT stock ended at $0.571. This is 17.77% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 30.36% from a day low at $0.560 to a day high of $0.730.
90 days $0.560 $0.94
52 weeks $0.560 $2.37

Historical DBV Technologies S.A. prices

Date Open High Low Close Volume
Nov 25, 2016 $36.03 $36.45 $35.89 $36.45 18 543
Nov 23, 2016 $35.05 $35.94 $34.56 $35.84 74 918
Nov 22, 2016 $36.17 $36.27 $35.67 $36.03 72 308
Nov 21, 2016 $35.90 $36.66 $35.90 $36.62 45 726
Nov 18, 2016 $36.21 $36.34 $35.90 $35.94 44 286
Nov 17, 2016 $36.25 $36.72 $36.23 $36.51 36 720
Nov 16, 2016 $36.49 $36.54 $36.00 $36.08 82 795
Nov 15, 2016 $36.70 $36.94 $36.35 $36.48 99 767
Nov 14, 2016 $36.60 $36.72 $36.00 $36.39 65 988
Nov 11, 2016 $36.67 $36.85 $36.30 $36.79 77 586
Nov 10, 2016 $36.16 $37.05 $35.90 $36.85 129 347
Nov 09, 2016 $35.07 $36.78 $35.01 $36.64 206 384
Nov 08, 2016 $35.61 $36.42 $35.48 $36.08 54 046
Nov 07, 2016 $35.00 $35.69 $34.98 $35.66 38 200
Nov 04, 2016 $34.20 $34.84 $34.15 $34.67 62 200
Nov 03, 2016 $34.34 $34.44 $33.99 $34.37 133 700
Nov 02, 2016 $34.11 $34.15 $33.53 $34.01 54 900
Nov 01, 2016 $34.22 $34.35 $33.70 $34.03 71 800
Oct 31, 2016 $34.65 $34.81 $34.14 $34.33 61 400
Oct 28, 2016 $35.37 $35.48 $34.58 $35.18 81 300
Oct 27, 2016 $36.80 $36.95 $35.97 $35.97 215 100
Oct 26, 2016 $36.31 $36.58 $35.85 $36.16 32 500
Oct 25, 2016 $37.37 $37.76 $36.31 $36.39 119 000
Oct 24, 2016 $35.50 $35.62 $34.93 $35.31 47 900
Oct 21, 2016 $35.57 $35.72 $35.25 $35.57 34 000
Click to get the best stock tips daily for free!

About DBV Technologies S.A.

DBV Technologies S.A. DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical t... DBVT Profile

Golden Star

Ticker Date Change Price
PAG May 07 1.87% $153.22
WMT May 06 0.95% $59.87
UNP May 06 3.09% $239.21
JPM May 06 2.86% $192.00
ASH May 03 2.10% $95.85
INVH May 03 1.72% $34.39
INGR May 03 4.72% $114.56
VCSH May 03 0.0260% $76.93
BNDX May 03 0.205% $48.68
BBCA May 03 1.93% $65.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT